NIMG-43. IMAGING FINDINGS FOLLOWING REGORAFENIB IN PATIENTS WITH MALIGNANT GLIOMA: FET PET ADDS VALUABLE INFORMATION TO ANATOMICAL MRI

BACKGROUND: Recent phase 2 data showed that the small molecule regorafenib with antiangiogenic properties has promising effectivity in glioblastoma patients at first progression. Following antiangiogenic therapy with bevacizumab, amino acid PET provides valuable additional diagnostic information reg...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Werner, Jan-Michael, Tscherpel, Caroline, Stoffels, Gabriele, Lohmann, Philipp, Fink, Gereon R, Langen, Karl-Josef, Galldiks, Norbert
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Neuroimaging
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651557/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.656
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items